Pubdate: Mon, 14 Jan 2008
Source: Canadian Medical Association Journal (Canada)
Copyright: 2008 Canadian Medical Association
Contact:  http://www.cmaj.ca/
Details: http://www.mapinc.org/media/754
Author: Karen Leslie, MD Division of Adolescent Medicine and 
Department of Paediatrics, Hospital for Sick Children, Toronto, Ont.

PUBLIC HEALTH

Youth Substance Use And Abuse: Challenges And Strategies For 
Identification And Intervention

Jeremy is 17 and has lived on the street for 3 years. He visits the 
emergency department for the fifth time in the past month reporting 
chest pain: "My heart's jumping out of my chest. Think I'm having a 
heart attack or something." He further reports symptoms of anxiety 
and panic attacks. He admits to using cannabis daily, and cocaine and 
ecstasy several times a week. The emergency physician takes a few 
minutes to ask Jeremy about his health concerns. Jeremy says he wants 
"to know that I'm not crazy." The physician wonders why Jeremy has 
not visited the substance abuse treatment agency he has been referred 
to and subsequently allays his fear that he will be "locked up" if he 
goes for treatment. With Jeremy's permission, the physician leaves a 
message for a worker at the street youth centre where Jeremy often 
hangs out. The following week, the worker accompanies Jeremy for an 
assessment at the treatment agency and to an appointment to see a 
psychiatrist. With support from the youth centre, Jeremy applies to 
stay at a group home to stabilize his living situation while he seeks 
treatment.

The above case illustrates the complexities involved in the 
assessment of and intervention for young people with substance abuse 
disorders, as well as the importance of understanding their 
perspectives on their difficulties and motivations for changing their 
substance use behaviour.

Drug and alcohol use is common among young people. Health Canada's 
Youth Smoking Survey 2004-20051 of Canadian youth in grades 5-9 
indicated that the mean age for first use of alcohol was just over 11 
years. The survey indicated that, among grade 7-9 students (ages 
12-14), 12.6 years was the mean age for first use of cannabis, and 
that 12.5% of these students reported ever using a substance other 
than alcohol, tobacco or cannabis. Substance use and abuse are 
associated with short-and long-term health and psychosocial risks. 
Therefore, it is imperative for workers in health care and other 
professions involved with youth (e.g., education, child protection, 
legal) to understand the prevalence of youth substance use and abuse, 
the associated morbidities and, most importantly, effective 
strategies for identification and intervention.

Prevalence of substance use and abuse

Table 1 lists common street drugs and their effects. A number of 
surveys collect information about the prevalence and trends of 
alcohol and drug use. The Centre for Addiction and Mental Health has 
conducted the Ontario Student Drug Use Survey2 biannually for 3 
decades, using an anonymous self-reporting method. The 2007 survey 
data indicated that 64.7% of youth in grades 7-12 reported lifetime 
use of alcohol, 29.9% cannabis, 4.3% cocaine and less than 4% other 
drugs, including heroin, ketamine and crystal methamphetamine.2 Other 
provinces have carried out surveys that revealed similar prevalence 
and trends, with few regional variations. The Ontario Student Drug 
Use Survey reported that rates of drug use (with the exception of 
inhalant use) increased with age during adolescence and were similar 
among boys and girls. Recent trends for most drugs have shown 
declining or steady rates of use.

The survey also revealed that 26.3% of students in grades 7-12 
reported binge drinking (5 or more drinks at one time) in the 4 weeks 
before the survey.2 In addition, 19% of the students surveyed 
reported hazardous drinking based on the AUDIT (Alcohol Use Disorders 
Identification Test)3 (Box 1) and 15% of the students responded 
positively to 2 or more items on the 6-item CRAFFT scale4 (Box 2), 
which is commonly used to identify the need for further assessment or 
intervention. Only 1.5% of the students reported obtaining treatment 
services in the year before the survey.

A relatively small proportion (1%-2%) of youth reported the 
nonmedical use (also referred to as misuse) of stimulant medication, 
including methylphenidate (Ritalin). However, recent data suggested 
that the misuse of prescription opiate medication in the year before 
the survey was as high as 24% among grade 9 students.2

Such surveys do not capture substance use and abuse by street youth, 
youth not attending school, those in correctional facilities or 
Native Canadian youth residing on reserves, all of whom have higher 
reported rates of substance use than youth in the general 
population.5 In particular, street youth have significantly higher 
rates of use of methamphetamine, ecstasy 
(methylenedioxymethamphetamine), cocaine and ketamine than youth in 
the general population. They are also more likely to be involved with 
injection drug use, which magnifies the potential for adverse health outcomes.6

Comparative international data are difficult to find, as there is 
much variation in survey methods. In general, tobacco and alcohol are 
the most frequently used substances by young people, with cannabis 
use accounting for 90% or more of the illicit drug use in North 
America, Australia and Europe.7 The United Nations Office on Drugs 
and Crime Global Youth Network reports that the prevalence of 
lifetime use of cannabis among 15- and 16-year-old students in 1999 
was 4.5%-5% in Asia, 1%-35% in various regions of Europe, 40.9% in 
the United States, 42.8% in Australia and 42.7% in Ontario, Canada.7

Risk factors

A number of risk factors have been associated with substance abuse 
among young people (Box 3). According to a 2007 report on youth 
substance use in Canada, up to 50% of youth who seek substance abuse 
treatment have been found to have a concurrent mental health 
disorder, such as depression or anxiety.5 Many risk factors occur 
simultaneously, thus there are subsets of youth for whom the 
likelihood of substance abuse is very high.

Research in the area of adolescent neurodevelopment suggests that 
adolescents' brains may be more vulnerable to the effects of 
substances. This research also shows that adolescents may be at risk 
of developing patterns of behaviour that result in substance abuse 
(continued use regardless of physical or psychosocial problems, or 
dependence) and substance dependence (physiologic dependence 
demonstrated by withdrawal symptoms or the development of tolerance 
to alcohol or drugs).8

Harms associated with substance use and abuse

There is an array of health-related harms associated with substance 
use and abuse. Many high-risk behaviours result from drug and alcohol 
use. These include having unplanned, unwanted and unprotected sexual 
activity; driving while intoxicated; being a passenger in a car while 
the driver is intoxicated; failing to wear a seat belt; and 
self-injurous behaviour such as cutting and suicide attempts. For 
example, 8%-10% of teens who participated in a 2003 Council of 
Ministers of Education study reported that using drugs or alcohol was 
the reason they had sexual intercourse for the first time.9 
Unprotected sexual activity is associated with a higher incidence of 
sexually transmitted infections and can lead to unintended pregnancy.

Substance use can cause acute medical complications (Table 1). 
Polysubstance use frequently complicates the presentation and 
management of these patients in emergency departments. The reported 
frequency of medical complications from substance use is likely 
underestimated, since some young people are reluctant to seek medical 
help because of concern about parental notification or legal involvement.

Youth with substance abuse problems are at increased risk of being 
involved with the legal system. They are also at risk of their 
education being interrupted or negatively affected.10,11 The complex 
interaction of physical, mental, legal, educational and social issues 
among youth with substance abuse problems creates the potential for 
poor short-and long-term outcomes.

Identification and treatment

Many health care practitioners do not routinely screen adolescents 
for substance use and associated risk factors. A number of screening 
tools are available, from the general assessment tools such as the 
HEADSS assessment (a mneumonic that forms the basis for a 
psychosocial assessment)12 and GAPS (Guidelines for Adolescent 
Prevention Services),13 to more specific tools for alcohol and 
substance abuse such as AUDIT3 (Box 1) and CRAFFT4 (Box 2), both of 
which have been validated for use with adolescents. A score of 2 or 
higher on the CRAFFT scale identifies a problem with substance use 
(sensitivity 76%, specificity 94% as compared with a structured 
psychiatric diagnostic interview).4

Urine drug testing is used in many adult substance abuse treatment 
programs. In the United States, random urine screening has been 
recommended for adolescents, particularly those involved in high 
school extracurricular activities. However, there is no evidence in 
the literature that random drug testing of adolescents has any 
therapeutic benefit.14 Further research is needed to determine 
whether there is any role for drug testing as a component of 
developmentally focused interventions for adolescents.

The evidence for effective treatment approaches for adolescents with 
substance abuse problems is limited and rigorous research in this 
area is lacking. Historically, treatments have used an 
abstinence-based approach (i.e., the expected outcome of treatment is 
no use of alcohol or drugs). Evidence from the literature 
demonstrates that programs for adolescents using a pure 
abstinence-based approach (the "just say no" approach) are 
ineffective in reducing substance use and abuse.15

There is growing recognition that harm-reduction strategies may be 
effective.16,17 Such strategies accept that adolescents may choose to 
use alcohol or drugs, and acknowledge that alcohol and drug abuse 
have potential health and psychosocial risks. Unlike abstinence-based 
approaches, which focus on eliminating the behaviour, harm-reduction 
strategies aim to reduce related risks by modifying the behaviour 
(which may include eliminating use). Interventions incorporating 
harm-reduction strategies have been successfully implemented and 
evaluated.17-19 Motivational interviewing techniques incorporate the 
need to address issues, such as ambivalence or resistance to 
treatment and change. Some studies have suggested this type of 
intervention leads to a reduction in harm associated with drug use 
and is a promising area for further study.15,18,19

To date, there are no compelling data to support a role for 
pharmacologic agents in the treatment of substance abuse problems in 
adolescents, although this is an emerging area of research focus. The 
exception is the treatment of concurrent mood disorders (e.g., 
depression), for which treatment has been found to reduce substance use.20

Despite our understanding about the prevalence and associated risks 
of adolescent substance use and abuse, there remain numerous 
challenges. There is still much to be discovered about effective 
prevention and youth-specific intervention strategies. It is 
important that the chosen approach be aligned with the developmental 
needs of the adolescent and, when appropriate, able to provide family 
support and treatment.21 In addition to reduction of substance use 
and abuse, health outcomes need to be examined in a broad context, 
including social functioning, legal involvement (or lack thereof), 
educational achievement, and physical and mental health.

Health care practitioners can play a key role in the identification 
of at-risk youth and of those who already have substance abuse 
problems. Practitioners should advocate on behalf of individuals to 
ensure that they have access to treatment services and at the 
community level to ensure that appropriate resources are directed 
toward effective interventions.

Footnotes

This article has been peer reviewed.

Competing interests: None declared.

REFERENCES

1. Youth Smoking Survey 2004-2005. Ottawa: Health Canada. Available: 
www.hc-sc.gc.ca/hl-vs/tobac-tabac/research-recherche/stat/survey-sondage/2004-2005/index_e.html 
(accessed 2007 Nov 29).

2. Adlaf EM, Paglia-Boak A. Drug use among Ontario students, 
1977-2007: detailed OSDUS findings [CAMH Research Document series no. 
20]. Toronto: Centre for Addiction and Mental Health; 2007.

Available: 
www.camh.net/Research/Areas_of_research/Population_Life_Course_Studies/OSDUS/OSDUHS2007_DrugDetailed_final.pdf 
(accessed 2007 Nov 29).

3. Saunders JB, Aasland OG, Babor TF, et al. Development of the 
Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative 
project on early detection of persons with harmful alcohol 
consumption. Addiction 1993;88:791-804.[CrossRef][Medline]

4. Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT 
substance abuse screening test among adolescent clinic patients. Arch 
Pediatr Adolesc Med 2002;156:607-14.[Abstract/Free Full Text]

5. Canadian Centre on Substance Abuse. Substance abuse in Canada: 
youth in focus. Ottawa: The Centre; 2007. Available: 
www.ccsa.ca/NR/rdonlyres/5D418288-5147-4CAC-A6E4-6D09EC6CBE13/0/ccsa0115212007e.pdf 
(accessed 2007 Nov 29).

6. Roy E, Lemire N, Haley N, et al. Injection drug use among street 
youth: a dynamic process. Can J Public Health 1998;89:239-40.[Medline]

7. United Nations Office on Drugs and Crime Global Youth Network. 
World situation with regard to drug abuse, with particular reference 
to children and youth. Vienna: The Network; 2001. Available: 
www.unodc.org/youthnet/youthnet_youth_drugs.html (accessed 2007 Nov 29).

8. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry 
of motivation in adolescence: a critical period of addiction 
vulnerability. Am J Psychiatry 2003;160:1041-52.[Abstract/Free Full Text]

9. Council of Ministers of Education. Sexuality and secual health. 
In: Canadian Youth, Sexual Health and HIV/AIDS Study: factors 
influencing knowledge, attitudes and behaviours. Toronto: The 
Council; 2003. p. 55-130. Available: www.cmec.ca/publications/aids/ 
(accessed 2007 Nov 29).

10. Johnson TP, Cho y, Fendrich M, et al. Treatment need and 
utilization among youth entering the juvenile corrections system. 
Journal of Substance Abuse Treatment 2004;26:117-28.[CrossRef][Medline]

11. Register CA, Williams DR, Grimes PW. Adolescent Drug Use and 
Educational Attainment. Education Economics 2001;9(1):1-18.[CrossRef]

12. Goldenring JM, Rosen DS. Getting into adolescent heads: an 
essential update. Contemp Pediatr 2004;21:64-90.

13. Elster A, Kuznets N. AMA guidelines for adolescent preventive 
services (GAPS). Baltimore: Williams & Wilkins; 1994.

14. Committee on Substance Abuse, American Academy of Pediatrics; 
Council on School Health, American Academy of Pediatrics, Knight JR, 
et al. Testing for drugs of abuse in children and adolescents: 
addendum-testing in schools and at home. Pediatrics 
2007;119:627-30.[Abstract/Free Full Text]

15. Marlatt GA, Witkiewitz K. Harm reduction approaches to alcohol 
use: health promotion, prevention, and treatment. Addict Behav 
2002;27: 867-86.[CrossRef][Medline]

16. Toumbourou JW, Stockwell T, Neighbors C, et al. Interventions to 
reduce harm associated with adolescent substance use. Lancet 
2007;369:1391-401.[CrossRef][Medline]

17. Poulin C. Harm reduction policies and programs for youth. In: 
Harm reduction for special populations in Canada. Ottawa: Canadian 
Centre on Substance Abuse; 2006. p. 1-16.

18. Monti PM, Colby SM, Barnett NP, et al. Brief intervention for 
harm reduction with alcohol-positive older adolescents in a hospital 
emergency department. J Consult Clin Psychol 1999;67:989-94.[CrossRef][Medline]

19. Martin G, Copeland J, Swift W. The adolescent cannabis check-up: 
feasibility of a brief intervention for young cannabis users. J Subst 
Abuse Treat 2005;29:207-13.[CrossRef][Medline]

20. Waxmonsky JG. Wilens pharmacotherapy of adolescent substance use 
disorders: a review of the literature. J Child Adolesc 
Psychopharmacol 2005;15:810-25.[CrossRef][Medline]

21. Currie J. Canada' s Drug Strategy, Health Canada. Treatment and 
rehabilitation for youth with substance use problems. Ottawa; 2001 
Available: 
www.hc-sc.gc.ca/hl-vs/pubs/adp-apd/youth-jeunes/index_e.html 
(accessed 2007 Nov 29).
- ---
MAP posted-by: Jay Bergstrom